IL Science (Korea) Performance
| 307180 Stock | KRW 2,895 30.00 1.03% |
IL Science has a performance score of 6 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 0.0656, which attests to not very significant fluctuations relative to the market. As returns on the market increase, IL Science's returns are expected to increase less than the market. However, during the bear market, the loss of holding IL Science is expected to be smaller as well. IL Science today owns a risk of 2.39%. Please check out IL Science Co semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to decide if IL Science Co will be following its current price history.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in IL Science Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, IL Science may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
| Total Cashflows From Investing Activities | -3 B |
307180 |
IL Science Relative Risk vs. Return Landscape
If you would invest 263,000 in IL Science Co on December 22, 2024 and sell it today you would earn a total of 26,500 from holding IL Science Co or generate 10.08% return on investment over 90 days. IL Science Co is generating 0.1934% of daily returns and assumes 2.3873% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than 307180, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
IL Science Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IL Science's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IL Science Co, and traders can use it to determine the average amount a IL Science's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.081
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 307180 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.39 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average IL Science is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IL Science by adding it to a well-diversified portfolio.
IL Science Fundamentals Growth
307180 Stock prices reflect investors' perceptions of the future prospects and financial health of IL Science, and IL Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 307180 Stock performance.
| Return On Equity | -19.27 | |||
| Return On Asset | -0.0949 | |||
| Profit Margin | (0.12) % | |||
| Operating Margin | (0.15) % | |||
| Current Valuation | 103.02 B | |||
| Shares Outstanding | 4.36 M | |||
| Price To Sales | 1.04 X | |||
| Revenue | 48.63 B | |||
| EBITDA | (2.65 B) | |||
| Cash And Equivalents | 7.05 B | |||
| Cash Per Share | 153.18 X | |||
| Total Debt | 6.41 B | |||
| Debt To Equity | 2.99 % | |||
| Cash Flow From Operations | (7.12 B) | |||
| Total Asset | 72.86 B | |||
About IL Science Performance
By analyzing IL Science's fundamental ratios, stakeholders can gain valuable insights into IL Science's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if IL Science has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IL Science has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
IL Science Co., Ltd. develops, produces, and installs LED lights, solar light systems, and environmentally friendly products. The company was founded in 2008 and is based in Seongnam, South Korea. IL SCIENCE is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about IL Science performance evaluation
Checking the ongoing alerts about IL Science for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IL Science help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| IL Science Co has accumulated 6.41 B in total debt with debt to equity ratio (D/E) of 2.99, implying the company greatly relies on financing operations through barrowing. IL Science has a current ratio of 0.81, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist IL Science until it has trouble settling it off, either with new capital or with free cash flow. So, IL Science's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IL Science sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for 307180 to invest in growth at high rates of return. When we think about IL Science's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 48.63 B. Net Loss for the year was (7.68 B) with profit before overhead, payroll, taxes, and interest of 2.39 B. | |
| IL Science Co has accumulated about 7.05 B in cash with (7.12 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 153.18. | |
| Roughly 36.0% of IL Science shares are owned by insiders or employees |
- Analyzing IL Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IL Science's stock is overvalued or undervalued compared to its peers.
- Examining IL Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IL Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of IL Science's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IL Science's stock. These opinions can provide insight into IL Science's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 307180 Stock analysis
When running IL Science's price analysis, check to measure IL Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IL Science is operating at the current time. Most of IL Science's value examination focuses on studying past and present price action to predict the probability of IL Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IL Science's price. Additionally, you may evaluate how the addition of IL Science to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |